WO2008003999A1 - Electrochemical detection of amine compounds - Google Patents
Electrochemical detection of amine compounds Download PDFInfo
- Publication number
- WO2008003999A1 WO2008003999A1 PCT/GB2007/050373 GB2007050373W WO2008003999A1 WO 2008003999 A1 WO2008003999 A1 WO 2008003999A1 GB 2007050373 W GB2007050373 W GB 2007050373W WO 2008003999 A1 WO2008003999 A1 WO 2008003999A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- working electrode
- naphthoquinone
- sulphonate
- undergoing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 0 *C(C(*)N*)c1c(*)c(*)c(*)c(*)c1* Chemical compound *C(C(*)N*)c1c(*)c(*)c(*)c(*)c1* 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/302—Electrodes, e.g. test electrodes; Half-cells pH sensitive, e.g. quinhydron, antimony or hydrogen electrodes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/48707—Physical analysis of biological material of liquid biological material by electrical means
- G01N33/48714—Physical analysis of biological material of liquid biological material by electrical means for determining substances foreign to the organism, e.g. drugs or heavy metals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/946—CNS-stimulants, e.g. cocaine, amphetamines
Definitions
- the present invention relates to the detection of amine compounds, in particular amphetamine compounds.
- Amphetamines such as 3,4-methylenedioxymethamphetamine (ecstasy) are recreational drugs of abuse due to their stimulant and euphoric effects.
- the physiological effects of ecstasy and related derivatives include confusion, paranoia, depression and sleeplessness.
- Adverse physical effects include muscle tension, involuntary teeth clenching, nausea, blurred vision, feeling faint, tremors, rapid eye movement, and sweating or chills.
- Amines may be detected colorimetrically by labelling with sodium 1 ,2-naphthoquinone-4- sulphonate in a solution-based reaction (Campins-Falco et al, Journal of Chromatography. B, Biomedical applications, 1996, 687, 239; Hashimato et al, Mikrochimica Acta, 1978, 2, 493; and Nakahara et al, J. Chrom., 1989, 489, 371 ). Detection may be achieved using spectrophotometric analysis coupled with high- performance liquid chromatography (HPLC). However, these techniques are of limited practical utility outside the laboratory owing to their complexity, and the size and cost of the equipment needed.
- HPLC high- performance liquid chromatography
- the present invention is based at least in part on a discovery that the reaction between an amine compound and 1 ,2-naphthoquinone-4-sulphonate can be detected electrochemically in situ.
- 1 ,2-naphthoquinone-4-sulphonate and amine-substituted derivatives thereof can be detected electrochemically, thereby providing a means for detecting amine compounds indirectly.
- the invention allows amphetamines and other amine compounds to be detected simply and rapidly compared with techniques such as HPLC, which are time consuming and expensive.
- the invention is therefore particularly relevant to the roadside testing of amphetamines in drug drivers.
- the invention provides a method of detecting an amine compound in a sample, which comprises contacting the sample with a second compound in the presence of a working electrode and an electrolyte, wherein said second compound is capable of undergoing a reaction with the amine compound, and wherein said second compound and/or a product of said reaction is capable of undergoing a redox reaction at the working electrode having a detectable redox couple; and determining the electrochemical response of the working electrode thereto.
- an electrochemical sensor for the detection of an amine compound which comprises a working electrode, a counter electrode, an electrolyte solution and a second compound, wherein said second compound is capable of undergoing a reaction with the amine compound, and wherein said second compound and/or a product of said reaction is capable of undergoing a redox reaction at the working electrode having a detectable redox couple.
- a further aspect of the invention concerns the use of a 1 ,2-naphthoquinone-4- sulphonate compound or a salt thereof, for the electrochemical detection of an amine compound.
- the invention also provides an electrode material comprising a 1 ,2-naphthoquinone-4- sulphonate compound.
- Fig. 1 shows linear sweep voltammetry at an edge plane pyrolytic graphite before (dotted line) and after 800 ⁇ M addition of D-amphetamine sulphate 2 mins (dotted and dashed line) and 10 minutes (solid line).
- Fig. 2 shows linear sweep voltammetry (A) at an edge plane pyrolytic graphite electrode resulting from 80, 160, 240, 320, 400, 480, 560, 640, 720, and 800 ⁇ M additions of D- amphetamine sulphate into an aqueous solution containing 1 mM sodium 1 ,2- naphthoquinone-4-sulphonate with 0.1 M sodium hydrogen carbonate and 0.01 M sodium carbonate (pH 9.1 ).
- the dotted line is the initial linear sweep voltamogram before the addition of any amphetamines.
- Fig. 3 depicts linear sweep voltammetry (A) at an edge plane pyrolytic graphite electrode resulting from 80, 160, 240, 320, 480, 560, 640, 720, 800, 880 and 960 ⁇ M additions of
- the dotted line is the initial linear sweep voltamogram before the addition of any amphetamines.
- the voltammetric waves are from additions of 0, 80, 160, 240, 320, 480, 560, 640, 720, 880 and 960 ⁇ M.
- B shows the analysis of peak height versus added D- amphetamine sulphate additions.
- Fig. 4 shows linear sweep voltammetry at an edge plane pyrolytic graphite electrode in 6 ml_ of oral (saliva) fluid containing 1 mM sodium 1 ,2-naphthoquinone-4-sulphonate with 0.1 M sodium carbonate.
- the dotted line is the initial linear sweep voltamogram before the addition of 1 mM D-amphetamine sulphate.
- Linear sweep voltammetry was recorded at 0, 2, 4, 6, 8, 10, 12, 14, 16, 18 and 20 minutes.
- Fig. 5A depicts linear sweep voltammetry at an edge plane pyrolytic graphite electrode resulting from 240, 320, 400, 480, 560, 640, 720, 800, 880, 960 and 1040 ⁇ M additions of pseudoephedrine into artificial saliva containing 1 mM sodium 1 ,2-naphthoquinone-4- sulphonate with 0.1 M sodium hydrogen carbonate (pH 8.2).
- the dotted line is the initial linear sweep voltamogram before the addition of any pseudoephedrine.
- Voltammetric curves shown are from additions of 240, 400, 560, 720, 880, 1040 ⁇ M.
- Fig. 5B shows the analysis of peak height (from A) versus added concentration. Description of Various Embodiments
- the amine compound may comprise a primary, secondary or tertiary amine group, usually a primary or secondary amine group.
- the amine compound may be in the form of a salt, typically obtained by mixing the compound with an acid addition salt.
- the salt may be a pharmaceutically acceptable salt.
- the amine compound may be an amphetamine compound.
- amphetamine compound as used herein includes reference to compounds comprising a phenylethylamine moiety, which may be substituted or unsubstituted.
- amphetamine compounds may be obtained in the form of single enantiomer or diastereomer, or a racemic mixture.
- Amphetamine compounds, especially those illustrated below, may be obtained in salt form, e.g. in the form of a hydrochloride or sulphate salt.
- the amine compound is an amphetamine compound of the formula (I):
- R 1 is hydrogen or a moiety comprising 1 to 30 plural valent atoms selected from C, N, O and S;
- R 2 and R 3 are each independently selected from hydrogen, halogen and moieties comprising 1 to 30 plural valent atoms selected from C, N, O and S;
- R 4 , R 5 , R 6 , R 7 and R 8 are each independently selected from hydrogen, halogen and moieties comprising 1 to 30 plural valent atoms selected from C, N, O and S; or any of R 4 and R 5 , R 5 and R 6 , R 6 and R 7 , and R 7 and R 8 taken together with the atoms to which they are attached may form a cyclic group optionally substituted with 1 , 2, 3, 4 or 5 R 9 ; and
- each R 9 is independently selected from hydrogen, halogen and moieties comprising 1 to 30 plural valent atoms selected from C, N, O and S;
- R 1 and R 2 are often each independently selected from hydrogen and Ci -6 alkyl (e.g. C 1 , C 2 , C 3 or C 4 alkyl).
- R 1 and R 2 are each independently selected from hydrogen and methyl.
- R 1 is hydrogen or methyl
- R 2 is methyl.
- R 3 is often selected from hydrogen, hydroxy, Ci -6 alkyl (e.g. C 1 , C 2 , C 3 or C 4 alkyl) and Ci- 6 alkoxy (e.g. C 1 , C 2 , C 3 or C 4 alkoxy).
- R 3 may be selected from hydrogen or hydroxy.
- R 4 , R 5 , R 6 , R 7 and R 8 are usually each independently selected from hydrogen, halogen, hydroxy, Ci -6 alkyl (e.g. C 1 , C 2 , C 3 or C 4 alkyl) and Ci -6 alkoxy (e.g. C 1 , C 2 , C 3 or C 4 alkoxy).
- R 4 , R 5 , R 6 , R 7 and R 8 are each hydrogen.
- one or more of R 4 and R 5 , R 5 and R 6 , R 6 and R 7 , and R 7 and R 8 taken together with their attached atoms forms a cyclic group optionally substituted with 1 , 2, 3, 4 or 5 R 9 ; and the others are each hydrogen.
- R 5 and R 6 taken together form a methylenedioxy bridge, in which case R 4 , R 7 and R 8 are often each hydrogen.
- amphetamine compounds examples include:
- a salt e.g. a pharmaceutically acceptable salt, thereof.
- the presence of an amine compound in the sample may be detected by contacting the sample with a second compound in the presence of a working electrode and electrolyte, wherein the second compound is capable of reacting with the amine compound in an electrochemically detectable reaction.
- the sample may be a liquid sample, for example an aqueous sample.
- the sample may comprise a body fluid, such as blood, urine or an oral fluid (e.g. saliva).
- the amine compound may be detected by determining the electrochemical response of the working electrode to the consumption of a reactant and/or the formation of a product of the reaction with the second compound, wherein said reactant or product is capable of undergoing a redox reaction at the working electrode having a detectable redox couple.
- the second compound may have an electrochemically detectable redox couple; in this case, the amine compound can be detected by determining the response of the working electrode to the consumption of the second compound.
- a product of the reaction may have an electrochemically detectable redox couple; in this case, the amine compound can be detected by determining the response of the working electrode to the formation of that product.
- the product may be an amine- substituted derivative of the second compound.
- the amine compound is contacted with a second compound which is 1 ,2-naphthoquinone-4-sulphonate compound or a salt thereof.
- the amine compound may be contacted with 1 ,2-naphthoquinone-4-sulphonate or a salt thereof.
- sodium 1 ,2-naphthoquinone-4-sulphonate is sodium 1 ,2-naphthoquinone-4-sulphonate.
- 1 ,2-naphthoquinone-4-sulphonate compound is capable of undergoing a reduction to a 1 ,2-naphthohydroquinone-4-sulphonate via a reversible 2-proton, 2-electron process. Since 1 ,2-naphthoquinone-4-sulphonate has a detectable redox couple, the amine compound may be detected by determining the electrochemical response of the working electrode to the consumption of the compound. This may be achieved, for example, by detecting a reduction in the magnitude of the voltammetric peak corresponding to Pathway A.
- the 1 ,2-naphthoquinone-4-sulphonate compound is reacted with an amine to form an amine-substituted 1 ,2-naphthoquinone compound.
- This reaction preferably takes place in the presence of one or more carbonates, e.g. selected from sodium carbonate and hydrogen carbonate.
- the reaction of a 1 ,2-naphthoquinone-4-sulphonate compound with an amine may produce a variety of other products, each of which may be electrochemically detectable.
- sodium 1 ,2-naphthoquinone-4-sulphonate is known to react with primary amines at room temperature to form a complex mixture of products (Hartke et al, Chem. Lett., 1983, 693).
- the amine-substituted 1 ,2-naphthoquinone compound can be reduced via a 2-proton, 2- electron process to form an amine-substituted 1 ,2-naphthohydroquinone compound; this process is shown as Pathway C in Scheme 1 and is analagous to Pathway A.
- the amine compound may also be detected by determining the electrochemical response of the working electrode to the formation of the amine-substituted 1 ,2- naphthoquinone compound or another product. This may be achieved by detecting growth of a voltammetric peak corresponding to the reaction of Pathway C.
- the amine compound may be detected using an electrochemical sensor containing a working electrode with which the sample may be contacted.
- electrochemical sensors are based upon the configuration of an electrochemical cell, comprising a working electrode, a counter electrode and an electrolyte, for example.
- the sensor may further comprise a reference electrode. Suitable sensor designs are well known in the art.
- the working electrode may be any suitable electrode known in the art, for example a metallic or carbon electrode.
- metallic electrodes include gold, silver and platinum electrodes.
- carbon electrodes include an edge plane pyrolytic graphite electrode, a basal plane pyrolytic graphite electrode, a glassy carbon electrode, a boron doped diamond electrode, a highly ordered pyrolytic graphite electrode, carbon powder and carbon nanotubes.
- edge plane pyrolytic graphite working electrodes may be a microelectrode or a macroelectrode, and may be screen printed.
- the counter electrode may be any suitable electrode, for example, a platinum or graphite electrode.
- the second compound may be present in solution, for example the electrolyte solution. Alternatively or additionally, the working electrode may comprise the second compound. Thus, the second compound may be present in the electrolyte solution and/or on the surface of the working electrode and/or in the working electrode.
- the second compound may act as the electrolyte.
- An electrolyte solution may therefore be obtained simply by adding the second compound to a liquid sample, e.g. an aqueous sample.
- a liquid sample e.g. an aqueous sample.
- an electrolyte solution may be obtained by dissolving a 1 ,2- naphthoquinone-4-sulphonate compound or a salt thereof in an aqueous liquid.
- the electrolyte preferably also contains one or more carbonate compounds, for example selected from sodium carbonate and hydrogen carbonate.
- the liquid to which the electrolyte is added may be the sample itself. Alternatively, the electrolyte solution may be obtained using a liquid other than the sample. If the second compound is not capable of acting as an electrolyte, then a supporting electrolyte can be used to form the electrolyte solution.
- a working electrode comprising the second compound may be obtained by immobilising the second compound on the electrode from solution.
- the second compound may be comprised in the bulk of the electrode material.
- a potential may be applied across the electrodes using a potentiostat, and the response of the cell to the sample determined.
- the applied potential may be varied relative to a reference electrode; in this way, a cyclic voltammogram may be obtained.
- the amperometric response of the cell can be determined by applying a fixed potential across the electrodes, optionally controlled relative to a reference electrode.
- the reference electrode may be, for example, a saturated calomel electrode (SCE) or a silver electrode.
- the current is measured using linear sweep or cyclic voltammetry. In another embodiment, said current is measured using square wave voltammetry. In an alternative embodiment, the current is measured using a pulsed voltammetry technique, in particular differential pulse voltammetry.
- Oral (saliva) fluid was provided by a volunteer. Prior to the sample being collected, the subject conducted two oral rinses with water. It is was requested that the subject did not eat for up to two hours prior to obtaining the sample to reduce the likelihood of the analysis being contaminated with particulate food.
- Example 1 Detection of sodium 1 ,2-naphthoquinone-4-sulphonate and D-amphetamine sulphate
- Linear sweep voltammetry was first used to explore the voltammetric response of an edge plane pyrolytic graphite electrode in an aqueous solution containing 1 mM sodium 1 ,2-naphthoquinone-4-sulphonate with 0.1 M sodium hydrogen carbonate and 0.01 M sodium carbonate (pH 9.1 ).
- Fig. 2 depicts the voltammetric profiles (Fig. 2A) before (dotted line) and after additions of D-amphetamine sulphate, along with analysis of the peak height versus added concentration shown in Fig. 2B.
- the increasing magnitude of the voltammetric peak at ca. - 0.52 V provides an analytically useful signal from which to determine D- amphetamine sulphate. Reduction in the voltammetric peak height at ca. - 0.17 V may also be conveniently used.
- Fig. 3 shows the response of additions of amphetamines into artificial saliva containing 1 mM sodium 1 ,2-naphthoquinone-4-sulphonate with 0.1 M sodium hydrogen carbonate
- Fig. 4 shows the linear sweep voltammetry response before any amphetamine addition (dotted line). No second peak was observed, indicating that the presence of proteins in the oral fluid did not affect the voltammetric response, thus minimising the possibility of false positives in testing.
- Fig. 5 depicts the linear sweep voltammetric response of 1 mM sodium 1 ,2- naphthoquinone-4-sulphonate with 0.1 M sodium hydrogen carbonate (pH 8.2) in artificial saliva towards additions of pseudoephedrine. Again, analytically useful signals were observed which can be used for monitoring the presence of amphetamines. Comparison of the analysis of peak in Fig. 3 with Fig.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Electrochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0823048A GB2452208B (en) | 2006-07-03 | 2007-07-03 | Electrochemical detection of amine compounds |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0613182.5A GB0613182D0 (en) | 2006-07-03 | 2006-07-03 | Method of detection |
| GB0613182.5 | 2006-07-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2008003999A1 true WO2008003999A1 (en) | 2008-01-10 |
Family
ID=36888535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/GB2007/050373 Ceased WO2008003999A1 (en) | 2006-07-03 | 2007-07-03 | Electrochemical detection of amine compounds |
Country Status (2)
| Country | Link |
|---|---|
| GB (2) | GB0613182D0 (en) |
| WO (1) | WO2008003999A1 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010092322A1 (en) | 2009-02-13 | 2010-08-19 | Oxtox Limited | Methods of assaying for tetrahydrocannabinol |
| US8877038B2 (en) | 2008-04-24 | 2014-11-04 | Oxtox Limited | Electrochemical assay |
| EP3001184A4 (en) * | 2013-05-07 | 2017-03-22 | Universitat de Valéncia | Passive device for the detection and/or determination in situ of amines in gases |
| CN110045053A (en) * | 2019-04-30 | 2019-07-23 | 华南理工大学 | A kind of QuEChERS pre-treating method of the analysis of the amphetamines suitable for blood |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0794429A1 (en) * | 1996-03-07 | 1997-09-10 | Matsushita Electric Industrial Co., Ltd. | Cholesterol sensor |
| WO2005085825A1 (en) * | 2004-03-04 | 2005-09-15 | Isis Innovation Ltd | Electrochemical sensors |
| WO2006009328A1 (en) * | 2004-07-23 | 2006-01-26 | Canon Kabushiki Kaisha | Enzyme electrode, sensor, fuel cell, and electrochemical reactor |
-
2006
- 2006-07-03 GB GBGB0613182.5A patent/GB0613182D0/en not_active Ceased
-
2007
- 2007-07-03 WO PCT/GB2007/050373 patent/WO2008003999A1/en not_active Ceased
- 2007-07-03 GB GB0823048A patent/GB2452208B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0794429A1 (en) * | 1996-03-07 | 1997-09-10 | Matsushita Electric Industrial Co., Ltd. | Cholesterol sensor |
| WO2005085825A1 (en) * | 2004-03-04 | 2005-09-15 | Isis Innovation Ltd | Electrochemical sensors |
| WO2006009328A1 (en) * | 2004-07-23 | 2006-01-26 | Canon Kabushiki Kaisha | Enzyme electrode, sensor, fuel cell, and electrochemical reactor |
Non-Patent Citations (6)
| Title |
|---|
| EVERETT W RUSSELL ET AL: "Mediated bioelectrocatalytic determination of organophosphorus pesticides with a tyrosinase-based oxygen biosensor", ANAL CHEM; ANALYTICAL CHEMISTRY FEB 15 1998 ACS, WASHINGTON, DC, USA, vol. 70, no. 4, 15 February 1998 (1998-02-15), pages 807 - 810, XP002453484 * |
| FALCO P C ET AL: "Improved amphetamine and methamphetamine determination in urine by normal-phase high-performance liquid chromatography with sodium 1,2-naphthoquinone 4-sulphonate as derivatizing agent and solid-phase extraction for sample clean-up", JOURNAL OF CHROMATOGRAPHY B : BIOMEDICAL APPLICATIONS, ELSEVIER SCIENCE PUBLISHERS, NL, vol. 663, no. 2, 20 January 1995 (1995-01-20), pages 235 - 245, XP004043681, ISSN: 0378-4347 * |
| GOODWIN ALEXANDER ET AL: "Tagging of model amphetamines with sodium 1,2-naphthoquinone-4-sulfo nate: Application to the indirect electrochemical detection of amphetamines in oral (saliva) fluid", ELECTROANALYSIS, vol. 18, no. 18, September 2006 (2006-09-01), pages 1833 - 1837, XP002453485, ISSN: 1040-0397 * |
| KRAEMER T ET AL: "Determination of amphetamine, methamphetamine and amphetamine-derived designer drugs or medicaments in blood and urine", JOURNAL OF CHROMATOGRAPHY B: BIOMEDICAL SCIENCES & APPLICATIONS, ELSEVIER, AMSTERDAM, NL, vol. 713, no. 1, 21 August 1998 (1998-08-21), pages 163 - 187, XP004127091, ISSN: 1570-0232 * |
| MAZEIKIENE R ET AL: "Doping of polyaniline by some redox active organic anions", EUROPEAN POLYMER JOURNAL, PERGAMON PRESS LTD. OXFORD, GB, vol. 36, no. 7, July 2000 (2000-07-01), pages 1347 - 1353, XP004193814, ISSN: 0014-3057 * |
| MOLINER-MARTINEZ Y ET AL: "Detector supports: application to aliphatic amines in wastewater", TALANTA, ELSEVIER, AMSTERDAM, NL, vol. 65, no. 1, 15 January 2005 (2005-01-15), pages 217 - 222, XP004638027, ISSN: 0039-9140 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8877038B2 (en) | 2008-04-24 | 2014-11-04 | Oxtox Limited | Electrochemical assay |
| WO2010092322A1 (en) | 2009-02-13 | 2010-08-19 | Oxtox Limited | Methods of assaying for tetrahydrocannabinol |
| EP3001184A4 (en) * | 2013-05-07 | 2017-03-22 | Universitat de Valéncia | Passive device for the detection and/or determination in situ of amines in gases |
| CN110045053A (en) * | 2019-04-30 | 2019-07-23 | 华南理工大学 | A kind of QuEChERS pre-treating method of the analysis of the amphetamines suitable for blood |
Also Published As
| Publication number | Publication date |
|---|---|
| GB0823048D0 (en) | 2009-01-28 |
| GB2452208B (en) | 2011-06-08 |
| GB0613182D0 (en) | 2006-08-09 |
| GB2452208A (en) | 2009-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Boumya et al. | Electrochemical sensors and biosensors for the determination of diclofenac in pharmaceutical, biological and water samples | |
| Tajik et al. | First report for simultaneous determination of methyldopa and hydrochlorothiazide using a nanostructured based electrochemical sensor | |
| Švorc et al. | Voltammetric determination of penicillin V in pharmaceutical formulations and human urine using a boron-doped diamond electrode | |
| javad Tavakoli et al. | Application of Gd2ZnMnO6/ZnO nanocomposite for electrochemical measurement of acetaminophen, diphenhydramine, and phenylephrine | |
| Sochr et al. | Electrochemical determination of adrenaline in human urine using a boron-doped diamond film electrode | |
| Golcu et al. | Anodic voltammetric behavior and determination of cefixime in pharmaceutical dosage forms and biological fluids | |
| Beni et al. | Cyclic and pulse voltammetric study of dopamine at the interface between two immiscible electrolyte solutions | |
| Demircigil et al. | Electrochemical behavior of formoterol fumarate and its determination in capsules for inhalation and human serum using differential‐pulse and square‐wave voltammetry | |
| Yiğit et al. | Voltammetric sensor based on boron-doped diamond electrode for simultaneous determination of paracetamol, caffeine, and aspirin in pharmaceutical formulations | |
| Zhang et al. | A novel electrochemical sensor based on reduced graphene oxide–TiO2 nanocomposites with high selectivity for the determination of hydroxychloroquine | |
| Karimi-Maleh et al. | Electrocatalytic determination of captopril in real samples using NiO nanoparticle modified (9, 10-dihydro-9, 10-ethanoanthracene-11, 12-dicarboximido)-4-ethylbenzene-1, 2-diol carbon paste electrode | |
| Saleh et al. | Adsorptive square wave voltammetric determination of the antiviral drug valacyclovir on a novel sensor of copper microparticles–modified pencil graphite electrode | |
| Câmpean et al. | Voltammetric determination of some alkaloids and other compounds in pharmaceuticals and urine using an electrochemically activated glassy carbon electrode | |
| Oliveira et al. | Potentiometric determination of Diclofenac using an ion-selective electrode prepared from polypyrrole films | |
| WO2008003999A1 (en) | Electrochemical detection of amine compounds | |
| Ghoneim et al. | Determination of trimetazidine HCl by adsorptive stripping square-wave voltammetry at a glassy carbon electrode | |
| Atif et al. | Novel nontoxic electrochemical method for the detection of cefadroxil in pharmaceutical formulations and biological samples | |
| Abbar et al. | Electrochemical determination of a hemorheologic drug, pentoxifylline at a multi-walled carbon nanotube paste electrode | |
| Wang et al. | Carbon-fiber microsensor for in vivo monitoring of trace zinc (II) based on electrochemical stripping analysis | |
| Al-Ghamdi et al. | Electrochemical determination of Cephalothin antibiotic by adsorptive stripping voltammetric technique | |
| Gatea et al. | A new method for measuring dopamine in the presence of uric acid employing a carbon paste electrode modified with the UiO-66 metal organic framework-graphene oxide nanocomposite | |
| Quintino et al. | Bia-amperometric quantification of salbutamol in pharmaceutical products | |
| Stefan-van Staden et al. | Pattern recognition of neurotransmitters using multimode sensing | |
| Mbokou Foukmeniok et al. | New electrochemical carbon paste electrode (CPE) based on Arabic Gum modifier and dedicated to 4-aminophenol | |
| Fernandez-Abedul et al. | Flow injection analysis with amperometric detection of naltrexone in pharmaceuticals |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07733794 Country of ref document: EP Kind code of ref document: A1 |
|
| ENP | Entry into the national phase |
Ref document number: 0823048 Country of ref document: GB Kind code of ref document: A Free format text: PCT FILING DATE = 20070703 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 0823048.4 Country of ref document: GB |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| NENP | Non-entry into the national phase |
Ref country code: RU |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 07733794 Country of ref document: EP Kind code of ref document: A1 |